Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep;47(9):1490.
doi: 10.1111/jcpt.13651. Epub 2022 Mar 21.

Comment on "Persistent remission of acromegaly in a patient with GH-secreting pituitary adenoma: Effect of treatment with pasireotide long-acting release and consequence of treatment withdrawal"

Adrian F Daly  1
Affiliations
Free article
Comment

Comment on "Persistent remission of acromegaly in a patient with GH-secreting pituitary adenoma: Effect of treatment with pasireotide long-acting release and consequence of treatment withdrawal"

Adrian F Daly. J Clin Pharm Ther. 2022 Sep.
Free article
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Yu N, Wang L, Yang H, Pan H, Duan L, Zhu H. Persistent remission of acromegaly in a patient with GH-secreting pituitary adenoma: effect of treatment with pasireotide long-acting release and consequence of treatment withdrawal. J Clin Pharm Ther. 2022. doi:10.1111/JCPT.13615. Online ahead of print.
    1. Chiloiro S, Giampietro A, Bianchi A, et al. Acromegaly can be cured by first-line pasireotide treatment? Endocrine. 2019;64:196-199. doi:10.1007/S12020-019-01874-4/FIGURES/3
    1. Coopmans EC, Van MSWF, Pieterman KJ, et al. Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinoma. Eur J Endocrinol. 2019;181:K21-K27. doi:10.1530/EJE-19-0279
    1. Yamamoto R, Shima KR, Igawa H, et al. Impact of preoperative pasireotide therapy on invasive octreotide-resistant acromegaly. Endocr J. 2018;65:1061-1067. doi:10.1507/ENDOCRJ.EJ17-0487
    1. Daly AF, Potorac I, Petrossians P, Beckers A. Shrinkage of pituitary adenomas with pasireotide. Lancet Diabetes Endocrinol. 2019;7:509. doi:10.1016/S2213-8587(19)30181-0

MeSH terms

LinkOut - more resources